天津九安医疗电子股份有限公司 关于回购公司股份的进展公告

Core Viewpoint - The company has approved a share repurchase plan with a total funding amount between 250 million RMB and 500 million RMB, aiming to enhance shareholder value and stabilize stock prices [1]. Summary by Sections Share Repurchase Plan - The company will use its own funds and special loan funds for the repurchase, with a maximum repurchase price set at 50 RMB per share [1]. - The total number of shares repurchased will be determined at the end of the repurchase period [1]. Progress of Share Repurchase - As of March 31, 2025, the company has repurchased a total of 1,193,900 shares, accounting for 0.25% of the total share capital [1]. - The highest transaction price was 42.17 RMB per share, while the lowest was 41.64 RMB per share, with a total expenditure of approximately 49.995 million RMB (excluding transaction fees) [1]. Compliance with Regulations - The company has adhered to relevant regulations regarding the timing, quantity, and pricing of the share repurchase [2][3]. - The repurchase does not occur during periods that could significantly impact the stock price or during other restricted periods as defined by regulatory authorities [2].